SPRY Financials

ARS Pharmaceuticals, Inc - Financial statements & key metrics

Stock Price

$5.77

Market Cap

$983.10M

P/E Ratio

72.1

EPS

$0.08

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$89.15M

Gross Profit

Operating Income

Net Income

$8.00M

EPS (Diluted)

$0.08

Balance Sheet Highlights

Total Assets

$351.15M

Total Liabilities

$94.36M

Shareholders Equity

Cash & Equivalents

$50.82M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$13.55M

CapEx

Free Cash Flow

Profitability Metrics

Net Margin

-200.0%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is SPRY revenue?

SPRY's most recent quarterly revenue was $89.15M. Annual revenue can be calculated by summing the four most recent quarters.

Is SPRY profitable?

SPRY reported a profit of $8.00M in the most recent quarter. The net profit margin is -200.0%.

What is SPRY market cap?

SPRY has a market capitalization of $983.10M, making it a small-cap stock.

Does SPRY have debt?

View SPRY's balance sheet for debt information.

What is SPRY cash flow?

Cash flow data is available in the full financial statements.